{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:15:25Z","timestamp":1790374525026,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1093\/infdis\/jix185","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T19:09:59Z","timestamp":1495134599000},"page":"S15-S23","source":"Crossref","is-referenced-by-count":22,"title":["Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame"],"prefix":"10.1093","volume":"216","author":[{"given":"Simona","family":"Zipursky","sequence":"first","affiliation":[{"name":"World Health Organization, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Patel","sequence":"additional","affiliation":[{"name":"Task Force for Global Health, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Farrell","sequence":"additional","affiliation":[{"name":"Programme Division, United Nations Children\u2019s Fund, New York, New York, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Ramirez","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasleem","family":"Kachra","sequence":"additional","affiliation":[{"name":"Bill & Melinda Gates Foundation, Seattle, Washington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Folly","sequence":"additional","affiliation":[{"name":"Gavi, the Vaccine Alliance, Geneva, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyrouz","family":"Kurji","sequence":"additional","affiliation":[{"name":"FDK Consulting, Kirkland, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal Laroche","family":"Veira","sequence":"additional","affiliation":[{"name":"Task Force for Global Health, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Wootton","sequence":"additional","affiliation":[{"name":"Gavi, the Vaccine Alliance, Geneva, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Hampton","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"key\n\t\t\t\t20180306121548_CIT0001","volume-title":"Poliomyelitis: intensification of the global eradication initiative","author":"World Health Organization","year":"2012"},{"key":"key\n\t\t\t\t20180306121548_CIT0002","author":"Global Polio Eradication Initiative"},{"key":"key\n\t\t\t\t20180306121548_CIT0003","volume-title":"Polio: an American story","author":"Oshinsky","year":"2005"},{"key":"key\n\t\t\t\t20180306121548_CIT0004","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1377\/hlthaff.2015.1079","article-title":"Gavi\u2019s transition policy: moving from development assistance to domestic financing of immunization programs","volume":"35","author":"Kallenberg","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"key\n\t\t\t\t20180306121548_CIT0005","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121548_CIT0006","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1098\/rstb.2011.0046","article-title":"Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience","volume":"366","author":"Hajjeh","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t20180306121548_CIT0007","doi-asserted-by":"crossref","first-page":"B81","DOI":"10.1016\/j.vaccine.2012.11.085","article-title":"Global support for new vaccine implementation in middle-income countries","volume":"31","author":"Kaddar","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121548_CIT0008","volume-title":"Poliomyelitis: intensification of the global eradication initiative","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180306121548_CIT0009","first-page":"59","article-title":"Expanded programme on immunization","volume":"41","author":"Keja","year":"1988","journal-title":"World Health Stat Q"},{"key":"key\n\t\t\t\t20180306121548_CIT0010","article-title":"Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines\u2014lessons learned from the global perspective","volume":"216 (suppl 1):S183\u201392","author":"Ramirez Gonzalez","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0011","doi-asserted-by":"crossref","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","article-title":"Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine\u2014worldwide, 2016","volume":"65","author":"Hampton","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180306121548_CIT0012","article-title":"Monitoring and validation of the global replacement of tOPV with bOPV, April\u2013May, 2016","volume":"216 (suppl 1): S193\u2013201","author":"Farrell","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0013","article-title":"Financial support to eligible countries for the switch from trivalent to bivalent oral polio vaccine\u2014lessons learned","volume":"216 (suppl 1):S52\u20136","author":"Shendale","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0014","article-title":"Exceptional financial support for introduction of inactivated polio vaccine in middle income countries","volume":"216 (suppl 1):S9\u201314","author":"Blankenhorn","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0015","article-title":"A supply and demand management perspective on the accelerated global introduction of inactivated polio vaccine in a constrained supply market","volume":"215 (suppl 4):S101\u20138","author":"Lewis","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0016","article-title":"Experience with inactivated polio vaccine introduction and the \u201cswitch\u201d from trivalent to bivalent oral polio vaccine in the World Health Organization\u2019s Western Pacific Region","volume":"215 (suppl 4):S33-9","author":"Gurung","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0017","article-title":"Introduction of inactivated polio vaccine, withdrawal of type 2 oral polio vaccine, and routine immunization strengthening in the Eastern Mediterranean Region","volume":"216 (suppl 1):S86-93","author":"Fahmy","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0018","article-title":"The switch from trivalent to bivalent oral poliovirus vaccine in the South-East Asia region","volume":"216 (suppl 1):S94\u2013100","author":"Bahl","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0019","article-title":"Systematization of the introduction of IPV and switch from tOPV to bOPV in the Americas","volume":"216 (suppl 1): S76\u201385","author":"Pedreira","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0020","first-page":"549","article-title":"Studies of missed opportunities for immunization in developing and industrialized countries","volume":"71","author":"Hutchins","year":"1993","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180306121548_CIT0021","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/infdis\/jit588","article-title":"Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil\u2019s National Immunization Program","volume":"210","author":"Domingues","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0022","volume-title":"WHO policy statement: multi-dose vial policy (MDVP)","author":"World Health Organization","year":"2014"},{"key":"key\n\t\t\t\t20180306121548_CIT0023","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.vaccine.2014.07.076","article-title":"Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: lessons for vaccine introduction","volume":"32","author":"Wallace","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121548_CIT0024","first-page":"261","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121548_CIT0025","article-title":"Administering multiple injectable vaccines\u2014summary of findings from the accelerated introduction of inactivated polio vaccine globally","volume":"216 (suppl 1):S152\u201360","author":"Dolan","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0026","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/j.vaccine.2016.07.021","article-title":"Acceptance of multiple injectable vaccines in a single immunization visit in The Gambia pre and post introduction of inactivated polio vaccine","volume":"34","author":"Idoko","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121548_CIT0027","article-title":"Acceptance of the administration of multiple injectable vaccines in a single immunization visit","volume":"216 (suppl 1):S146\u201351","author":"Preza","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121548_CIT0028","author":"India Expert Advisory Group for Polio Eradication","year":"2016"},{"key":"key\n\t\t\t\t20180306121548_CIT0029","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180306121548_CIT0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306121548_CIT0031","first-page":"266","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2016\u2014conclusions and recommendations","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_1\/S15\/24265083\/jix185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T17:16:19Z","timestamp":1520356579000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_1\/S15\/3935081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":31,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,7,1]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix185","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,1]]},"published":{"date-parts":[[2017,7,1]]}}}